🇺🇸 FDA
Pipeline program

Lubiprostone

STU00001168

Approved small_molecule completed

Quick answer

Lubiprostone for Constipation is a Approved program (small_molecule) at Takeda with 7 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Constipation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials